#NOACs
LightNews LightNews
tctmd.bsky.social
More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin
More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin
More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin sciprian@crf.org Fri, 02/14/2025 - 16:52 L.A. McKeown Major bleeding was low overall, but the findings align with other large datasets showing greater risk with rivaroxaban.
www.tctmd.com
February 14, 2025 at 10:05 PM
wolverinebear.bsky.social
Alzheimer’s: Common Blood Thinner May Slow Cognitive Decline www.healthline.com/health-news/...

#Alzheimers #dementia #Afib #neurology #cardiology #health
Alzheimer’s: Common Blood Thinner May Slow Cognitive Decline
A new study found that blood thinners called NOACs may slow cognitive decline in people with Alzheimer's who have atrial fibrillation (AFib). These individuals are prone to brain damage from "silent s...
www.healthline.com
August 18, 2026 at 6:49 PM
nejm.org
In patients with atrial fibrillation, left atrial appendage closure was noninferior to NOACs in an analysis of death from cardiovascular causes, stroke, or systemic embolism and was superior for non–procedure-related bleeding. Full CHAMPION-AF trial results: nej.md/4rSQuhY

#ACC26
A graph of the 3-year incidence of death from cardiovascular causes, stroke, or systemic embolism (primary composite efficacy end point).
March 28, 2026 at 2:37 PM
zimmermanv66.bsky.social
www.sciencedaily.com/releases/202...
These blood thinners may have an unexpected benefit for Alzheimer’s patients
Newer blood thinners may do more than prevent strokes in people with Alzheimer’s disease and atrial fibrillation. Researchers found that patients taking NOACs experienced a slower decline in cognitive...
www.sciencedaily.com
September 23, 2026 at 1:49 PM
angiopussy.bsky.social
the noacs really were novel
June 17, 2025 at 11:04 PM
zimmermanv66.bsky.social
www.sciencedaily.com/releases/202...
These blood thinners may have an unexpected benefit for Alzheimer’s patients
Newer blood thinners may do more than prevent strokes in people with Alzheimer’s disease and atrial fibrillation. Researchers found that patients taking NOACs experienced a slower decline in cognitive...
www.sciencedaily.com
September 22, 2026 at 12:46 PM
mariaoconnor.bsky.social
www.sciencedaily.com/releases/202...
These blood thinners may have an unexpected benefit for Alzheimer’s patients
Newer blood thinners may do more than prevent strokes in people with Alzheimer’s disease and atrial fibrillation. Researchers found that patients taking NOACs experienced a slower decline in cognitive...
www.sciencedaily.com
September 19, 2026 at 9:24 PM
nejm.org
In patients with atrial fibrillation, left atrial appendage closure was noninferior to NOACs in an analysis of death from cardiovascular causes, stroke, or systemic embolism and was superior for non–procedure-related bleeding. Full CHAMPION-AF trial results: https://nej.md/4rSQuhY
This image is from a Research Summary titled "Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation" published in the New England Journal of Medicine. It compares two treatments for atrial fibrillation: "Device-Based Left Atrial Appendage Closure" with 1499 participants and "Non–Vitamin K Antagonist Oral Anticoagulants" with 1501 participants. The top section includes statistics about the study participants and a diagram of the heart focused on the left atrial appendage. There is a call to action at the bottom to read the full Research Summary at NEJM.org.
June 8, 2026 at 1:00 PM
vjha.bsky.social
New study: NOACs like apixaban safe & effective for short-term prevention of blood clots in primary membranous nephropathy patients with low albumin—no VTEs, low bleeding risk. Promising alternative to warfarin! #Nephrology #VTE #PatientCare t.co/mSt3nhKMvm @isn-india.bsky.social
https://indianjnephrol.org/apixaban-in-primary-membranous-nephropathy-report-from-the-itangible-registry/
t.co
June 27, 2025 at 3:25 PM
davesnothereman1.bsky.social
www.healthline.com/health-news/... #Alzheimer's #Alzheimers #AD
Alzheimer’s: Common Blood Thinner May Slow Cognitive Decline
A new study found that blood thinners called NOACs may slow cognitive decline in people with Alzheimer's who have atrial fibrillation (AFib). These individuals are prone to brain damage from "silent s...
www.healthline.com
August 15, 2026 at 2:34 PM
cvrcbern.bsky.social
New publication: Left Atrial Appendage Occlusion Versus NOACs in patients With Atrial Fibrillation: Rationale and Design of the CATALYST Trial. Congratulation to the authors!
pubmed.ncbi.nlm.nih.gov/41638386/
Left Atrial Appendage Occlusion Versus NOACs in patients With Atrial Fibrillation: Rationale and Design of the CATALYST Trial - PubMed
URL https://clinicaltrials.gov; Unique Identifier NCT04226547.
pubmed.ncbi.nlm.nih.gov
April 14, 2026 at 7:03 AM
pirategamething.com
I believe most NOACs should support both. I'm not too privy on the technical details unfortunately
October 24, 2024 at 8:55 PM
jinternmed.bsky.social
Follow the discussion! Is a vitamin-K antagonist superior to #NOACs?

➡️ Letters to the Editor following a published original article!

🔹Regarding: doi.org/10.1111/joim...
🔹Authors reply: doi.org/10.1111/joim...
🔹Original Article: doi.org/10.1111/joim...

#anticoagulation
December 10, 2024 at 9:07 AM
kgusler.bsky.social
These blood thinners may have an unexpected benefit for Alzheimer’s patients
Newer blood thinners may do more than prevent strokes in people with Alzheimer’s disease and atrial fibrillation. Researchers found that patients taking NOACs experienced a slower decline in cognitive...
www.sciencedaily.com
September 18, 2026 at 11:52 AM
liverpoolccs.bsky.social
Clinical outcomes of rate control versus rhythm control as the initial strategy in atrial fibrillation: insights from the GLORIA-AF registry #Afib @livhp.bsky.social @livuniresearch.bsky.social link.springer.com/article/10.1...
Clinical outcomes of rate control versus rhythm control as the initial strategy in atrial fibrillation: insights from the GLORIA-AF registry - Internal and Emergency Medicine
In the era of non-vitamin K antagonist oral anticoagulants (NOACs), it remains unclear whether rate control versus rhythm control as an initial treatment strategy affects the prognosis of patients wit...
link.springer.com
March 6, 2026 at 10:16 AM
froqroj.bsky.social
#medicina
Y de pronto sacan un artículo que pone en duda la seguridad de los anticoagulantes de acción directa frente a los antagonistas de vitamina K. ¡Qué dolor de cabeza!
onlinelibrary.wiley.com/doi/10.1111/...

Esto va a dar que hablar...
<em>Journal of Internal Medicine</em> | Wiley Online Library
Background Vitamin-K antagonists (VKAs) have widely been replaced by non-VKA oral anticoagulants (NOACs). This includes Austria, Germany and Switzerland, where as VKA, instead of warfarin, the much ...
onlinelibrary.wiley.com
November 19, 2024 at 8:04 PM
caare.bsky.social
Karolinska Institutet analyzed 7,308 human patients with Alzheimer's and atrial fibrillation, finding that modern blood thinners (NOACs) slowed cognitive decline — a human-relevant insight unobtainable from animal experiments. news.ki.se/blood-thinni...
Blood-thinning medication linked to slower cognitive decline
People with both atrial fibrillation and Alzheimer’s disease who are treated with modern NOAC blood-thinning medicines may experience a slower rate of cognitive decline. This is shown by a study from ...
news.ki.se
August 27, 2026 at 1:08 PM
dr.maeker.fr
[Biblio au hasard]

Trouvez-vous cette référence suffisamment intéressante pour l’intégrer dans notre #veille #bibliographique #gériatrique AgingPapers ?

Cc @dr.maeker.fr ? https://pubmed.ncbi.nlm.nih.gov/39311651
1/4
Long-term cognitive function changes with non-vitamin K oral anticoagulants in older patients with atrial fibrillation. A multicenter cohort study - PubMed
In older patients with atrial fibrillation, the use of NOACs was associated with a smaller decline of cognitive function over time compared to the VKAs, regardless that patients in the NOACs group were older and with a higher burden of comorbidities.
pubmed.ncbi.nlm.nih.gov
September 28, 2025 at 1:07 AM
tctmd.bsky.social
Watch Martin Leon, Saibal Kar, and Ken Stein talk about the results from the CHAMPION-AF trial, which compares the WATCHMAN FLX LAAC device with NOACs as a first-line option for patients with nonvalvular atrial fibrillation. www.tctmd.com/CHAMPION-AF-...
April 28, 2026 at 3:27 PM
mariaoconnor.bsky.social
www.healthline.com/health-news/...
Alzheimer’s: Common Blood Thinner May Slow Cognitive Decline
A new study found that blood thinners called NOACs may slow cognitive decline in people with Alzheimer's who have atrial fibrillation (AFib). These individuals are prone to brain damage from "silent s...
www.healthline.com
August 15, 2026 at 8:19 PM
pirategamething.com
If I'm not mistaken, I believe VRT is basically the only one left making NOACs though? So modern non-FPGA clones might be fairly representative of compatibility but I'm not completely certain which chip they're using.
November 28, 2024 at 5:54 PM
erlangen.bsky.social
Newer blood thinners can do more than just prevent strokes & atrial fibrillation. Researchers found that patients taking NOACs (Eliquis [apixaban], rivaroxaban, edoxaban, dabigatran) experienced a slower decline in cognitive function
www.sciencedaily.com/releases/202...
These blood thinners may have an unexpected benefit for Alzheimer’s patients
Newer blood thinners may do more than prevent strokes in people with Alzheimer’s disease and atrial fibrillation. Researchers found that patients taking NOACs experienced a slower decline in cognitive...
www.sciencedaily.com
September 22, 2026 at 12:21 AM
pirategamething.com
it's hard to pinpoint what's correct sometimes! some chips never swapped them (um6561, um6578 - earlier noacs) and some others swap them in NTSC but not PAL. i think all VRT chips swapped them across the board until VT32 and VT369 but I might be wrong on that
February 14, 2025 at 11:11 AM
database-20.bsky.social
Before, I mentioned something about NES-based clone consoles. Now I look into the NES homebrew scene and see a new JRPG type game using a custom mapper called the MXM-1 which pushes the NES far past its graphical and audio limitations, exceeding most enhanced NOACs like the VTxx chips.
February 22, 2025 at 5:04 AM
drphilriley.bsky.social
🧠🏥 Interesting but not groundbreaking. Now use Full Neuropsych testing instead of MMSE and include WATCHMAN patients.

#CardioSky

academic.oup.com/eurheartj/ad...
Oral anticoagulants, cognition, and clinical outcomes in atrial fibrillation and Alzheimer’s disease: a Swedish nationwide study
AbstractBackground and Aims. Use of non-vitamin K oral anticoagulants (NOACs) is associated with reduced dementia risk in patients with atrial fibrillation
academic.oup.com
August 16, 2026 at 2:17 PM